Product image of Тектротид (Hynic-[d-Phe1,tyr3-Octreotide]*tfa) supplied by GNH India

Тектротид

Active Ingredient:
Hynic-[d-Phe1,tyr3-Octreotide]*tfa
Origin:
EU

Тектротид (Hynic-[d-Phe1,tyr3-Octreotide]*tfa)

Тектротид (Hynic-[d-Phe1,tyr3-Octreotide]*tfa) is a radiopharmaceutical used in diagnostic imaging procedures. This compound supports nuclear medicine applications for precise medical evaluations. Suitable for intravenous administration in clinical settings. Designed for compatibility with standard imaging protocols.

Manufacturer / TM Owner

Narodowe Centrum Badań Jądrowych

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Тектротид is primarily used in nuclear medicine imaging to assist in the detection of certain types of tumors and other abnormalities. It is employed in procedures where radiolabeled peptides are required for diagnostic purposes. This compound is particularly useful in imaging studies involving somatostatin receptor-positive tissues. It supports the evaluation of conditions such as neuroendocrine tumors.

Side Effects

  • When administered intravenously, Тектротид binds to specific receptors in the body, enabling targeted imaging of tissues with high receptor density. The effects are typically observed during diagnostic imaging sessions, where the compound helps highlight areas of interest for medical professionals. Its use is confined to clinical environments under controlled conditions.

Precautions & Warnings

  • Тектротид should only be handled by trained medical personnel in approved clinical settings. Proper radiation safety protocols must be followed to minimize exposure risks. Patients should disclose any known allergies or sensitivities prior to administration. Storage and disposal must comply with local regulations for radiopharmaceuticals.

Avoid Interactions

  • No specific drug interactions have been widely documented for Тектротид, as its use is confined to diagnostic imaging. However, patients should inform healthcare providers about all medications, supplements, or medical conditions before administration. Caution is advised when combining with other radiopharmaceuticals or imaging agents.

Frequently Asked Questions

Тектротид is used in nuclear medicine imaging to detect tumors and abnormalities in tissues with high receptor density.

Тектротид is administered intravenously in a clinical setting by trained medical professionals.

Side effects are rare but may include mild reactions at the injection site or allergic responses.

Patients should disclose all medications to their healthcare provider before administration.

Use is determined by medical professionals based on individual patient conditions and imaging needs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Hynic-[d-Phe1,tyr3-Octreotide]*tfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT